CRVS
Corvus Pharmaceuticals Inc
NASDAQ: CRVS · HEALTHCARE · BIOTECHNOLOGY
$15.19
+5.34% today
Updated 2026-04-30
Market cap
$1.35B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.53
Dividend yield
—
52W range
$3 – $27
Volume
1.3M
Corvus Pharmaceuticals Inc (CRVS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $0.00 | $148000.00 | $594000.00 | $842000.00 | $847000.00 | $743000.00 | $632000.00 | $460000.00 | $367000.00 | $151000.00 | $85000.00 | $105000.00 |
| Gross profit | $0.00 | $-148000.00 | $-594000.00 | $-842000.00 | $-847000.00 | $-743000.00 | $-632000.00 | $-460000.00 | $-367000.00 | $-151000.00 | $-85000.00 | $-105000.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $41455.00 | $11.35M | $29.36M | $46.30M | $38.59M | $37.98M | $31.83M | $29.11M | $24.47M | $16.53M | $19.39M | $33.72M |
| SG&A | $134182.00 | $2.42M | $7.62M | $10.22M | $10.64M | $10.88M | $11.93M | $9.52M | $8.10M | $6.88M | $8.16M | $9.25M |
| Operating income | $-176000.00 | $-13.77M | $-36.98M | $-56.52M | $-49.22M | $-48.85M | $-43.76M | $-38.63M | $-32.56M | $-23.41M | $-27.55M | $-42.97M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $14636.00 | $-31.19M | $-36.38M | $-55.68M | $-48.38M | $-48.11M | $-43.13M | $-38.17M | $-32.20M | $-23.26M | $-27.46M | $-42.97M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-161000.00 | $-31.34M | $-36.98M | $-56.52M | $-49.22M | $-48.85M | $-43.76M | $-38.63M | $-32.56M | $-23.41M | $-27.55M | $-43.08M |
| Interest expense | $0.00 | $0.00 | $601000.00 | $0.00 | $2.28M | $2.18M | $540000.00 | $15000.00 | $654000.00 | $1.58M | $1.82M | $2.50M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-176000.00 | $-31.34M | $-36.38M | $-55.66M | $-46.94M | $-43.75M | $-4.82M | $-43.24M | $-41.31M | $-27.03M | $-62.29M | $-15.28M |
| Net income growth (YoY) | — | -17704.0% | -16.1% | -53.0% | +15.7% | +6.8% | +89.0% | -796.6% | +4.5% | +34.6% | -130.5% | +75.5% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — |